Steroidogenic electron-transfer factors and their diseases

키워드

참고문헌 (111)

1. Miller WL, "The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders", Endocr Rev, 32, pp.81~151 (2011)
2. 김찬종, "Congenital lipoid adrenal hyperplasia", Annals of Pediatric Endocrinology & Metabolism, 19(4), pp.179~183 (2014), 대한소아내분비학회
3. Taninee Sahakitrungruang, "Clinical and molecular review of atypical congenital adrenal hyperplasia", Annals of Pediatric Endocrinology & Metabolism, 20(1), pp.1~7 (2015), 대한소아내분비학회
4. Jin-Ho Choi, "Recent advances in biochemical and molecular analysis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency", Annals of Pediatric Endocrinology & Metabolism, 21(1), pp.1~6 (2016), 대한소아내분비학회
5. Miller WL, "Disorders in the initial steps in adrenal steroidogenesis", J Steroid Biochem Mol Biol, 165, pp.18~37 (2017)
6. Miller WL, "Genetic disorders of vitamin D biosynthesis and degradation", J Steroid Biochem Mol Biol, 165, pp.101~108 (2017)
7. Miller WL, "Molecular biology of steroid hormone synthesis", Endocr Rev, 9, pp.295~318 (1988)
8. Voutilainen R, "Hormonal regulation of P450scc(20, 22desmolase)and P450c17(17α-hydroxylase", 17, 20 lyase)in cultured human granulosa cells, 1986, pp.63, 202~207
9. Miller WL, "Early steps in steroidogenesis : Intracellular cholesterol trafficking", J Lipid Res, 52, pp.2111~2135 (2011)
10. Bose HS, "Rapid regulation of steroidogenesis by mitochondrial protein import", Nature, 417, pp.87~91 (2002)
11. Toaff ME, "Metabolism of 25-hydroxycholesterol by rat luteal mitochondria and dispersed cells", Endocrinology, 111, pp.1785~1790 (1982)
12. Bose HS, "N-218 MLN64, a protein with StAR-like steroidogenic activity is folded and cleaved similarly to StAR", Biochemistry, 39, pp.11722~11731 (2000)
13. Cherradi N, "Submitochondrial distribution of three key steroidogenic proteins(steroidogenic acute regulatory protein and cytochrome P450scc and 3β-hydroxysteroid dehydrogenase isomerase enzymes)upon stimulation by intracellular calcium in adrenal glomerulosa cells", J Biol Chem, 272, pp.7899~7907 (1997)
14. Ortiz de Monellano PR, "Hydrocarbon hydroxylation by cytochrome P450 enzymes", Chem Rev, 110, pp.932~948 (2010)
15. Shaik S, "P450 Enzymes : their structure, reactivity, and selectivity—modeled by QM", MM Calculations, 2010, pp.110, 949~1017
16. Nebert DW, "Human cytochromes P450 in health and disease", Phil Trans Roy Soc B, 368, pp.20120431~ (2013)
17. Miller WL, "Minireview. Regulation of steroidogenesis by electron transfer", Endocrinology, 146, pp.2544~2550 (2005)
18. Solish SB, "Human adrenodoxin reductase : two mRNAs encoded by a single gene on chromosome 17cen→q25 are expressed in steroidogenic tissues", Proc Natl Acad Sci USA, 85, pp.7104~7108 (1988)
19. Lin D, "Cloning and sequence of the human adrenodoxin reductase gene", Proc Natl Acad Sci USA, 87, pp.8516~8520 (1990)
20. Coghlan VM, "Site-specific mutations in human ferredoxin that affect binding to ferredoxin reductase and cytochrome P450scc", J Biol Chem, 266, pp.18606~18612 (1991)
21. Brandt ME, "Expression and characterization of human mitochondrial ferredoxin reductase in Escherichia coli", Arch Biochem Biophys, 294, pp.735~740 (1992)
22. Bak DW, "Alternative FeS cluster ligands : tuning redox potentials and chemistry", Curr Opin Chem Biol, 19, pp.50~58 (2014)
23. Braymer JJ, "Iron-sulfur biogenesis and trafficking in mitochondria", J Biol Chem, 292, pp.12754~12763 (2017)
24. Maio N, "Outlining the complex pathway of mammalian Fe-S cluster biogenesis", Trends Biochem Sci, 45, pp.411~426 (2020)
25. Maio N, "Mammalian iron–sulfur cluster biogenesis : recent insights into the roles of frataxin, acyl carrier protein and ATPase-mediated transfer to recipient proteins", Curr Opin Chem Biol, 55, pp.34~44 (2020)
26. Zhang W, "Mammalian mitochondrial iron–sulfur cluster biogenesis and transfer and related human diseases", Biophys Rep, 7, pp.127~141 (2021)
27. Rouault TA, "Mammalian iron–sulphur proteins : novel insights into biogenesis and function", Nature Rev Mol Cell Biol, 16, pp.45~55 (2015)
28. Stehling O, "The role of mitochondria in cellular iron–sulfur protein biogenesis : mechanisms, connected processes, and diseases", Cold Spring Harbor Perspect Biol, 5, pp.a011312~ (2013)
29. Isaya G, "Mitochondrial iron–sulfur cluster dysfunction in neurodegenerative disease", Front Pharmacol, 5, pp.29~ (2014)
30. Valentine RC, "Bacterial ferredoxin", Bacteriol Rev, 28, pp.497~517 (1964)
31. Chashchin VL, "The primary structure of hepatoredoxin from bovine liver mitochondria", Bioorg Khim, 12, pp.1286~1289 (1986)
32. Okamura T, "Molecular cloning and amino acid sequence of the precursor form of bovine adrenodoxin. Evidence for a previously unidentified COOH-terminal peptide", Proc Natl Acad Sci USA, 82, pp.5705~5709 (1985)
33. Picado-Leonard J, "Human adrenodoxin : cloning of three cDNAs and cycloheximide enhancement in JEG-3 cells", J Biol Chem, 263, pp.3240~3244 (1988)
34. Mittal S, "Molecular cloning and sequence analysis of human placental ferredoxin", Arch Biochem Biophys, 264, pp.383~391 (1988)
35. Chang CY, "Cloning and structure of the human adrenodoxin gene", DNA, 7, pp.609~615 (1988)
36. Morel Y, "Assignment of the functional gene for adrenodoxin to chromosome 11q13→qter and of two adrenodoxin pseudogenes to chromosome 20cen→q13. 1", Am J Hum Genet, 43, pp.52~59 (1988)
37. Sparkes RS, "Regional mapping of genes encoding human steroidogenic enzymes : P450scc to 15q23-q24, adrenodoxin to 11q22, adrenodoxin reductase to 17q24-q25, and P450c17 to 10q24-q25", DNA Cell Biol, 10, pp.359~365 (1991)
38. Qi W, "Human ferredoxin-2 displays a unique conformational change", Dalton Trans, 42, pp.3088~3091 (2013)
39. Sheftel AD, "Humans possess two mitochondrial ferredoxins, Fdx1 and Fdx2, with distinct roles in steroidogenesis, heme, and Fe", S cluster biosynthesis, 2010, pp.107, 11775~11780
40. Shi Y, "Both human ferredoxins 1 and 2 and ferredoxin reductase are important for iron-sulfur cluster biogenesis", Biochim Biophys Acta, 1823, pp.484~492 (2012)
41. Cai K, "Human mitochondrial ferredoxin 1(FDX1)and ferredoxin 2(FDX2)both bind cysteine desulfurase and donate electrons for iron-sulfur cluster biosynthesis", Biochemistry, 56, pp.487~499 (2017)
42. Griffin A, "Ferredoxin 1b(Fdx1b)is the essential mitochondrial redox partner for cortisol biosynthesis in zebrafish", Endocrinology, 157, pp.1122~1134 (2016)
43. Oakes JA, "Ferredoxin 1b deficiency leads to testis disorganization, impaired spermatogenesis and feminization in zebrafish", Endocrinology, 160, pp.2401~2416 (2019)
44. Spiegel R, "Deleterious mutation in FDX1L gene is associated with a novel mitochondrial muscle myopathy", Euro J Hum Genet, 22, pp.902~906 (2014)
45. Gurgel-Giannetti J, "A novel complex neurological phenotype due to a homozygous mutation in FDX2", Brain, 141, pp.2289~2298 (2018)
46. Brentano ST, "cAMP posttranscriptionally diminishes the abundance of adrenodoxin reductase mRNA", Proc Natl Acad Sci USA, 89, pp.4099~4103 (1992)
47. Paul A, "FDXR mutations cause sensorial neuropathies and expand the spectrum of mitochondrial Fe-S-synthesis diseases", Am J Hum Genet, 101, pp.630~637 (2017)
48. Peng Y, "Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy", Hum Mol Genet, 26, pp.4937~4950 (2017)
49. Slone J, "Biallelic mutations in FDXR cause neurodegeneration associated with inflammation", J Hum Genet, 63, pp.1211~1222 (2018)
50. Slone JD, "Integrated analysis of the molecular pathogenesis of FDXR-associated disease", Cell Death and Disease, 11, pp.423~ (2020)
51. Stenton SL, "Expanding the clinical and genetic spectrum of FDXR deficiency by functional validation of variants of uncertain significance", Human Mutation, 42, pp.310~319 (2021)
52. Jurkute N, "Expanding the FDXR-associated disease phenotype : retinal dystrophy is a recurrent ocular feature", Invest Ophthalmol Vis Sci, 62, pp.2~ (2021)
53. Fairfield H, "Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders", Genome Res, 25, pp.948~957 (2015)
54. Baker BY, "Non-classic congenital lipoid adrenal hyperplasia : a new disorder of the steroidogenic acute regulatory protein with very late presentation and normal male genitalia", J Clin Endocrinol Metab, 91, pp.4781~4785 (2006)
55. Sahakitrungruang T, "Partial defect in the cholesterol side-chain cleavage enzyme, P450scc(CYP11A1)resembling non-classic congenital lipoid adrenal hyperplasia", J Clin Endocrinol Metab, 96, pp.792~798 (2011)
56. Pandey AV, "NADPH P450 oxidoreductase : structure, function, and pathology of diseases", Pharmacol Therap, 138, pp.229~254 (2013)
57. Wang M, "Three-dimensional structure of NADPH-cytochrome P450 reductase : prototype for FMN-and FAD-containing enzymes", Proc Natl Acad Sci USA, 94, pp.8411~8416 (1997)
58. Ellis J, "Domain motion in cytochrome P450reductase : conformational equilibria revealed by NMR and small-angle x-ray scattering", J Biol Chem, 284, pp.36628~36637 (2009)
59. Shen AL, "Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase", J Biol Chem, 277, pp.6536~6541 (2002)
60. Otto DM, "Identification of novel roles of the cytochrome P450 system in early embryogenesis : effects on vasculogenesis and retinoic acid homeostasis", Mol Cell Biol, 23, pp.6103~6116 (2003)
61. Flück CE, "Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome", Nature Genetics, 36, pp.228~230 (2004)
62. Huang N, "Diversity and function of mutations in P450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis", Am J Hum Genet, 76, pp.729~749 (2005)
63. Laue K, "Craniosynostosis and multiple skeletal anomalies in humans and zebrafish result from a defect in the localized degradation of retinoic acid", Am J Hum Genet, 89, pp.595~606 (2011)
64. Hershkovitz E, "Homozygous mutation G539R in the gene for P450 oxidoreductase in a family previously diagnosed as having 17, 20 lyase deficiency", J Clin Endocrinol Metab, 93, pp.3584~3588 (2008)
65. Sahakitrungruang T, "Clinical, genetic and enzymatic characterization of P450 oxidoreductase deficiency in four patients", J Clin Endocrinol Metab, 94, pp.4992~5000 (2009)
66. Fukami M, "Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and", or impaired steroidogenesis : molecular and clinical studies in 10 patients, 2005, pp.90, 414~426
67. Krone N, "Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency", J Clin Endocrinol Metab, 97, pp.E257~E267 (2012)
68. Geller DH, "The genetic and functional basis of isolated 17, 20 lyase deficiency", Nature Genet, 17, pp.201~205 (1997)
69. Geller DH, "P450c17 mutations R347H and R358Q selectively disrupt 17, 20 lyase activity by disrupting interactions with P450 oxidoreductase and cytochrome b5", Mol Endocrinol, 13, pp.167~175 (1999)
70. Adachi M, "Compound heterozygous mutations of cytochrome P450 oxidoreductase gene(POR)in two patients with Antley-Bixler syndrome", Am J Med Genet A, 128A, pp.333~339 (2004)
71. Fukami M, "Cytochrome P450 oxidoreductase deficiency in three patients initially regarded as having 21-hydroxylase deficiency and", or aromatase deficiency : diagnostic value of urine steroid hormone analysis, 2006, pp.59, 276~280
72. Shackleton C, "Prenatal diagnosis of P450 oxidoreductase deficiency (ORD): a disorder causing low pregnancy estriol, maternal and fetal virilization, and the Antley-Bixler syndrome phenotype", Am J Med Genet A, 129A, pp.105~112 (2004)
73. Pandey AV, "Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase", Mol Endocrinol, 21, pp.2579~2595 (2007)
74. Auchus RJ, "The backdoor pathway to dihydrotestosterone", Trends Endocrinol Metab, 15, pp.432~438 (2004)
75. Homma K, "Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency : implication for the backdoor pathway to dihydrotestosterone", J Clin Endocrinol Metab, 91, pp.2643~2649 (2006)
76. Huang N, "Genetics of P450 oxidoreductase : sequence variation in 842individuals of four ethnicities and activities of 15 missense mutants", Proc Natl Acad Sci USA, 105, pp.1733~1738 (2008)
77. O’Leary KA, "Thyroid regulation of NADPH : cytochrome P450 oxidoreductase : identification of a thyroid-responsive element in the 5’-flank of the oxidoreductase gene", Mol Pharmacol, 52, pp.46~53 (1997)
78. Li HC, "Transcriptional induction of hepatic NADPH : cytochrome P450 oxidoreductase by thyroid hormone", Mol Pharmacol, 59, pp.987~995 (2001)
79. Tee MK, "Transcriptional regulation of human P450 oxidoreductase : identification of transcription factors and influence of promoter polymorphisms", Mol Endocrinol, 25, pp.715~731 (2011)
80. Gomes LG, "The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency", J Clin Endocrinol Metab, 93, pp.2913~2916 (2008)
81. Agrawal V, "Pharmacogenetics of P450oxidoreductase. Effect of sequence variants on activities of CYP1A2 and CYP2C19", Pharmacogenet Genomics, 18, pp.569~576 (2008)
82. Ingelman-Sundberg M, "Polymorphism of cytochrome P450 and xenobiotic toxicity", Toxicology, 181-182, pp.447~452 (2002)
83. Weinshilboum R, "Inheritance and drug response", N Engl J Med, 348, pp.529~537 (2003)
84. Williams PA, "Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone", Science, 305, pp.683~686 (2004)
85. Ekroos M, "Structural basis for ligand promiscuity in cytochrome P450 3A4", Proc Natl Acad Sci USA, 103, pp.13682~13687 (2006)
86. Agrawal V, "Substratespecific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase(POR)", Pharmacogenet Genomics, 20, pp.611~618 (2010)
87. Sandee D, "Effects of genetic variants of P450oxidoreductase on catalysis by CYP2D6 in vitro", Pharmacogenet Genomics, 20, pp.677~686 (2010)
88. Miller WL, "Consequences of POR mutations and polymorphisms", Mol Cell Endocrinol, 336, pp.174~179 (2011)
89. Giordano S, "The human liver and reticulocyte cytochrome b5 mRNA's are products from a single gene", Biochim Biophys Res Commun, 178, pp.38~44 (1991)
90. Shephard EA, "Chromo somal localization of a cytochrome b5 gene to human chromosome 18 and a cytochrome b5 pseudogene to the X chromosome", Genomics, 11, pp.302~308 (1992)
91. Storbeck KH, "Cytochrome b5modulates multiple reactions in steroidogenesis by diverse mechanisms", J Steroid Biochem Mol Biol, 151, pp.66~73 (2015)
92. Bridges A, "Identification of the binding site on cytochrome P450 2B4 for cytochrome b5 and cytochrome P450reductase", J Biol Chem, 273, pp.17036~17049 (1998)
93. Yamazaki H, "Lack of electron transfer from cytochrome b5 in stimulation of catalytic activities of cytochrome P450 3A4. Characterization of a reconstituted cytochrome P450 3A4", NADPH-cytochrome P450 reductase system and studies of apo-cytochrome b5, 1996, pp.271, 27438~27444
94. Auchus RJ, "Cytochrome b5 augments the 17, 20 lyase activity of human P450c17 without direct electron transfer", J Biol Chem, 273, pp.3158~3165 (1998)
95. Pandey AV, "Regulation of 17, 20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17", J Biol Chem, 280, pp.13265~13271 (2005)
96. Yanagibashi K, "Role of electron transport in the regulation of the lyase activity of C21 side-chain cleavage P-450 from porcine adrenal and testicular microsomes", J Biol Chem, 26, pp.8429~8433 (1986)
97. Lin D, "Steroid 17α-hydroxylase and 17, 20 lyase activities of P450c17 : contributions of serine106 and of P450 reductase", Endocrinology, 132, pp.2498~2506 (1993)
98. Lee-Robichaud P, "Lysine mutagenesis identifies cationic charges of human CYP17that interact with cytochrome b5 to promote male sexhormone biosynthesis", Biochem J, 342, pp.309~312 (1999)
99. Swart AC, "A single amino acid residue Ala 105, confers 16α-hydroxylase activity to human cytochrome P450 17α-hydroxylase", 17, 20 lyase, 2010, pp.119, 112~120
100. Sherbet DP, "CYP17 mutation E305G causes isolated 17, 20 lyase deficiency by selectively altering substrate binding", J Biol Chem, 278, pp.48563~48569 (2003)
101. Zhang L, "Serine phosphorylation of human P450c17 increases 17, 20 lyase activity : implications for adrenarche and for the polycystic ovary syndrome", Proc Natl Acad Sci USA, 92, pp.10619~10623 (1995)
102. Pandey AV, "Protein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17", J Biol Chem, 278, pp.2837~2844 (2003)
103. Tee MK, "Phosphorylation of human cytochrome P450c17 by p38α selectively increases 17, 20 lyase activity and androgen synthesis", J Biol Chem, 288, pp.23903~23913 (2013)
104. Naffin-Olivos JL, "Human cytochrome b5 requires residues E48 and E49 to stimulate the 17, 20-lyase activity of cytochrome P450c17", Biochemistry, 24, pp.755~762 (2006)
105. Miller WL, "The syndrome of 17, 20 lyase deficiency", J Clin Endocrinol Metab, 97, pp.59~67 (2012)
106. Hegesh E, "Congenital methemoglobinemia with deficiency of cytochrome b5", New England J Med, 314, pp.757~761 (1986)
107. Giordano SJ, "A splicing mutation in the cytochrome b5 gene from a patient with congenital methemoglobinemia and pseudohermaphroditism", Human Genet, 93, pp.568~570 (1994)
108. Kok RC, "Isolated 17, 20 lyase deficiency due to the cytochrome b5 mutation W27X", J Clin Endocrinol Metab, 95, pp.994~999 (2010)
109. Idkowiak J, "A missense mutation in the human cytochrome b5gene causes 46, XY disorder of sex development due to true isolated 17, 20 lyase deficiency", J Clin Endocrinol Metab, 97, pp.E465~E475 (2012)
110. Leung MT, "Isolated 17, 20-lyase deficiency in a CYB5A mutated female with normal sexual development and fertility", J Endocr Soc, 4, pp.1~8 (2020)
111. Shaunak M, "Isolated 17,20 lyase deficiency secondary to a novel CYB5A variant: comparison of steroid metabolomic findings with published cases provides diagnostic guidelines and greater insight into its biological role", Horm Res Paediatr, 93, pp.483~495 (2020)

관련 논문AI추천